Disruption of the HER3-PI3K-mTOR oncogenic signaling axis and PD-1 blockade as a multimodal precision immunotherapy in head and neck cancerZhiyong Wang, J. Silvio Gutkind, Michael M. Allevato et al.|Nature Communications|2021Cited by 86